Haigh Adrian 4/A
4/A · FENNEC PHARMACEUTICALS INC. · Filed Apr 26, 2024
Insider Transaction Report
Form 4/AAmended
Haigh Adrian
Director
Transactions
- Exercise/Conversion
Common Shares
2024-04-17$2.31/sh+22,222$51,333→ 22,222 total - Exercise/Conversion
Common Shares
2024-04-18$2.31/sh+22,222$51,333→ 44,444 total
Footnotes (2)
- [F1]On April 18, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of "S" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 17, 2024, and an additional 22,222 common shares on April 18, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023. The correct transaction code for the reporting person's acquisition of these shares is "M".
- [F2]On April 18, 2024, the reporting person filed a Form 4 that mistakenly indicated a transaction code of "S" in Column 3 of Table I concerning the reporting person's acquisition of 22,222 common shares on April 17, 2024, and an additional 22,222 common shares on April 18, 2024, each pursuant to an option exercise pursuant to a 10b5-1 plan dated August 17, 2023. The correct transaction code for the reporting person's acquisition of these shares is "M".